Advertisement

Geriatric Diagnostic Imaging

  • Senan Nagaratnam
Chapter

Abstract

This review will highlight the improvements that have occurred in the safety of imaging in advanced age. The review will discuss the mechanisms that may give rise to interaction in the use of contrast in imaging. The review will briefly update the usefulness of imaging modalities in research and in clinical practice, for the purpose of the diagnosis and staging of the dementias. The diagnosis of dementia in the oldest old can be challenging. Currently there are an array of imaging modalities that are available for research and clinical use.

Keywords

Diagnostic imaging Computed tomography Magnetic resonance imaging Contrast-induced nephropathy (CIN) Acute renal injury 

Notes

Acknowledgements

I wish to thank Dr. Mark Wilkinson for his comments.

References

  1. 1.
    Website 1: German scientist discovers X-rays. http://www.history.com/this-day-in-history/german-scientist-discovers-x-rays. Accessed 3 Nov 2016.
  2. 2.
    Website 2: History of the X-ray. Australia’s Science Council. http://riaus.org.au/articles/history-of-the-x-rays/. Accessed 3 Nov 2016.
  3. 3.
    Website 3: Brief history of CT. http://www.imaginis.com/ct-scan/brief-history-of-ct. Accessed 3 Nov 20016.
  4. 4.
    Website 4: Spiral CT and helical CT. http://www.imaginis.com/ct-scan/spiral-ct-and-helical-ct-1. Accessed 3 Nov 2016.
  5. 5.
    Website 5: a short history of the magnetic resonance imaging (MRI). http://www.teslasociety.com/mri.htm. Accessed 3 Nov 2016.
  6. 6.
    Bullain SS, Corrado MM. Dementia in the oldest old. Continuum (Minneap Minn). 2013;19(2 Dementia):457–69.Google Scholar
  7. 7.
    US Census Bureau. Annual estimates of population by sex and five-year age groups for the United States: Apri11, 2000 to July1, 2007, 2008. May 2008. http://www.census.gov/popest/mational/arsh/NC-EST2007-sa.html. Accessed 6 Aug 2009.
  8. 8.
    Epstein M. Aging and the kidney. J Am Soc Nephrol. 1996;7(8):1106–22.PubMedGoogle Scholar
  9. 9.
    Dunnill MS, Halley W. Some observations on the quantitative anatomy of the kidney. J Pathol. 1973;11:121.Google Scholar
  10. 10.
    Porush JG, Faubert PF. Renal disease in elderly patients. Rev Clin Gerontol. 1997;7(4):299–307.CrossRefGoogle Scholar
  11. 11.
    Lameire N, Hste E, Van Lo A, Dondt A, Bernaert P, Vanholder R, et al. Pathophysiology causes and prognosis of acute renal failure in the elderly. Ren Fail. 1996;8:333–46.CrossRefGoogle Scholar
  12. 12.
    Abdel-Kader K, Palevsky P. Acute kidney injury in the elderly. Clin Geriatr Med. 2009;25(3):331–5.CrossRefGoogle Scholar
  13. 13.
    Shlipak MG, Katz R, Kestenbaum B, Fried LF, Newman AS, Siscorick S, et al. Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. Am J Nephrol. 2009;30(3):171–8.CrossRefGoogle Scholar
  14. 14.
    Fliser D, Franek E, Joest M, Block S, Mutdschler E, Ritz E. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int. 1997;5:1196–204.CrossRefGoogle Scholar
  15. 15.
    Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33:278–85.CrossRefGoogle Scholar
  16. 16.
    Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12.CrossRefGoogle Scholar
  17. 17.
    Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Wilborn TA, Zimmet PZ, et al. Prevalence of kidney damage in Australian adults: the Aus Diab kidney study. J Am Soc Nephrol. 2003;14(7):S131–8.CrossRefGoogle Scholar
  18. 18.
    White SL, Polkinghome KR, Atkins RC, Chadban SJ. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD epidemiology collaboration (CKD-EPI) and modification of diet in renal disease (MDRD) study GFR estimating equations: the Aus Diab (Australian diabetes, obesity and lifestyle study). Am J Kidney Dis. 2010;55:660–70.CrossRefGoogle Scholar
  19. 19.
    Convit P, Leon MJ, Hoptman MJ, Tarshish CM, De Santi S, Rusinek H. Age-related changes in the brain, i. Magnetic resonance imaging measures of temporal lobe volumes in normal subjects. Psychiatry Q. 1995;66(4):343–8.CrossRefGoogle Scholar
  20. 20.
    Raz N, Rodrique KM. Differential aging of the brain: patterns cognitive correlates and modifiers. Neurosci Biobehav Rev. 2006;30:730–48.CrossRefGoogle Scholar
  21. 21.
    Mu Q, Xie J, Wen Z, Shyun Z. Quantitative MR study of the hippocampal formation, the amygdala and the temporal horn of the lateral ventricle in healthy subjects 40-90 years of age. AJNR Am J Neuroradiol. 1999;20:207–11.PubMedGoogle Scholar
  22. 22.
    Yang Z, Sahdev PS. Brain imaging of the oldest old who aged successfully. Alas of Science. https://altlasofscience.org/brain-imaging-of-the-oldest-old-who-aged-successfully/
  23. 23.
    Berlau DJ, Corrado NMM, Peltz CB, Kawas CH. Disability in the oldest old: incidence and risk factors in the 90+ study. Am J Geriatr Psychiatry. 2012;20(2):159–68.CrossRefGoogle Scholar
  24. 24.
    Corrada MM, Brookmeyer R, Paganini-Hill A, Berlau D, Kawas CH. Dementia incidence continues to increase with age in the oldest old: the 90+ study. Ann Neurol. 2010;67910:59–168.Google Scholar
  25. 25.
    Kravitz E, Schmeidler J, Been MS. Cognitive decline and dementia I the oldest old. Rambam Maimonides Med J. 2012;3(4):e0026.CrossRefGoogle Scholar
  26. 26.
    Nybo H, Petersen HC, Gaist JD, Jeune B, Andersen K, McGue M, et al. Predictors of mortality in 2249 nonagenarians –the Dutch 1905 cohort study. J Am Geriatr Soc. 2013;52:1365–73.Google Scholar
  27. 27.
    Godwin M, Gadag V, Pike A, Pitcher H, Parsons K, McCrate F, et al. The healthy aged. Can Fam Physician. 2015;61(3):e142–7.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Nijveldt R, Pflederer T, Achenbach S. Coronary CT angiography in the elderly. Neth Hear J. 2014;22(3):124–5.CrossRefGoogle Scholar
  29. 29.
    Laugharne MJ, Paravasthu M, Preston A, Hill KO. CT pulmonary angiography in elderly patients: outcomes in patients aged >85 years. Clin Radiol. 2013;68(5):449–54.CrossRefGoogle Scholar
  30. 30.
    Wollman DE1, Beeri MS, Weinberger M, Cheng H, Silverman JM, Prohovnik I. Tolerance of MRI procedures by the oldest old. Magn Reson Imaging. 2004;22(9):1299–304.CrossRefGoogle Scholar
  31. 31.
    Scatliff JH, Morris PJ. From Roentgen to magnetic resonance imaging: the history of medical imaging. NC Med J. 2014;75(2):111–3.Google Scholar
  32. 32.
    Lam JY, Chaitman BR, Glaenzer M, Byers S, Fite J, Shah Y, et al. Safety and diagnostic accuracy of dipyridamole-thallium imaging in the elderly. J Am Coll Cardiol. 1988;11(3):585–9.CrossRefGoogle Scholar
  33. 33.
    Thomson KP, Varma DK. Safe use of radiographic contrast media. Aust Prescr. 2010;33:35–7.CrossRefGoogle Scholar
  34. 34.
    Barrett BJ, Parfrey PS. Prevention of nephrotoxicity induced by radiocontrast agents. NEJM. 1994;331:1449–50.CrossRefGoogle Scholar
  35. 35.
    Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. Genitourinary imaging. Am J Roentgenol (AJR). 2004;183(6):1673–89.CrossRefGoogle Scholar
  36. 36.
    Marcos SK, Thomsen HS, Webb JA, Members of the Contrast Media Safety Committee of the European Society of Urogenital Radiology (EIS). Contrast –media-induced nephrotoxicity: a consensus report. Eur Radiol. 1999;9:1602–13.CrossRefGoogle Scholar
  37. 37.
    Parra D, Legreid AM, Beckey NP, Reyes S. Metformin monitoring and change in serum creatinine levels in patients undergoing radiologic procedures involving administration of intravenous contrast media. Pharmacotherapy. 2004;24(8):987–93.CrossRefGoogle Scholar
  38. 38.
    Rasuli P, Hammond DI. Metformin and contrast media: where is the conflict? Can Assoc Radiol J. 1998;49(3):161–6.PubMedGoogle Scholar
  39. 39.
    McCartney MM, Gilbert FJ, Murchison LE, Pearson D, McHardy K, Murray AD. Metformin and contrast media-a dangerous combination? Clin Radiol. 1999;54(1):29–33.CrossRefGoogle Scholar
  40. 40.
    Benko A, Fraser-Hill M, Magner P, Capusten B, Barrett HB, Myers A, et al. Canadian Association of Radiologists Canadian Association of radiologists : consensus guidelines for the prevention of contrast-induced nephropathy. Can Assoc Radiol J. 2007;58:79–87.PubMedGoogle Scholar
  41. 41.
    Stacul F, van der Molen AJ, Reimer P, Webb JA, Thomsen HS, Morcos SK, Contrast Media Safety Committee of European Society of Radiology (ESUR), et al. Contrast induced nephropathy: updated ESUR contrast media safety committee guidelines [review]. Eur Radiol. 2011;21:2527–41.CrossRefGoogle Scholar
  42. 42.
    Oyarzum GM. Pulmonary function in aging. Rev Med Chil. 2009;137(3):411–8.Google Scholar
  43. 43.
    Janssens JP, Pache JC, Nicol NP. Physiological changes in respiratory function associated with aging. Eur Respir J. 1999;13:197–205.CrossRefGoogle Scholar
  44. 44.
    Hochhegger B, Meirelles GS, Irion K, Zanetti G, Garcia E, Moreira J, et al. The chest and aging: radiological findings. J Bras de Pneumol. 2012;38:5.  https://doi.org/10.1590/S1806-37132012000500016.CrossRefGoogle Scholar
  45. 45.
    Mereu M, Verdecchia M, D’Adessandro F, Cerasu B, Patea IL, Giammarini A, et al. Chest imaging I the elderly: what radiologist should know about.  https://doi.org/10.1594/esti2014/P-0061.
  46. 46.
    Gossner I, Nau R. Geriatric chest imaging: when and how to image the elderly lung, age-related changes and common pathologies. Radiol Res Pract. 2013;2013:1–9.  https://doi.org/10.1155/2013/584793.CrossRefGoogle Scholar
  47. 47.
    Sharma G, Goodwin J. Effect of aging on respiratory system physiology and immunology. Clin Interv Aging. 2006;1(3):253–60.CrossRefGoogle Scholar
  48. 48.
    Copley SJ, Wells AU, Hawtin KE, Gibson DJ, Hodson JM, Jacques AE, et al. Lung morphology in the elderly: comparative CT study of subjects over 75 years old versus those under 55 year old. Radiology. 2009;251(2):566–73.CrossRefGoogle Scholar
  49. 49.
    Caskey CI, Zerhouni EA, Fishman EK, Rahmoini AD. Aging of the diaphragm: a CT study. Radiology. 1989;171(2):385–9.CrossRefGoogle Scholar
  50. 50.
    Carmeli E, Reznick AZ. The physiology and biochemistry of skeletal muscle atrophy as a function of age. Pro Soc Exp Biol Med. 1994;206(2):103–13.CrossRefGoogle Scholar
  51. 51.
    Booth FW, Weeden SH, Tseng BS. Effect of aging on human skeletal muscle and motor function. Med Sci Sports Exerc. 1994;26(5):556–60.CrossRefGoogle Scholar
  52. 52.
    Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C. Age neuropathology and dementia. N Engl J Med. 2009;360:2302–9.CrossRefGoogle Scholar
  53. 53.
    Poon LW, Woodward JL, Stephen Miller L, Green R, Gearing M, Davey A, et al. Understanding dementia prevalence among centenarians. J Gerontol A Biol Sci Med Sci. 2012;67:358–65.CrossRefGoogle Scholar
  54. 54.
    Brown RK, Bohnen NI, Wong KK, Minoshima S, Frey KA. Brain PET in suspected dementia: patterns of altered FDG metabolism. Radiographics. 2014;34(3):684–701.CrossRefGoogle Scholar
  55. 55.
    Goedert M, Klug A, Crowther RA. Tau protein ,the paired helical filament and Alzheimer’s disease. J Alzheimers Dis. 2006;9(3Suppl):195–207.CrossRefGoogle Scholar
  56. 56.
    Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–59.CrossRefGoogle Scholar
  57. 57.
    Duyckaerts C, Perruchini C, Lebouvier T, Potiier MC. The lesions of Alzheimer’s disease: which therapeutic perspectives? Bull Acad Natl Med. 2008;192(2):303–18.PubMedGoogle Scholar
  58. 58.
    Braak H, Braak E, Bohl J, Bratzke H. Evolution of Alzheimer’s disease related to cortical regions. J Neural Transm Suppl. 1998;54:97–106.CrossRefGoogle Scholar
  59. 59.
    Bonifacio G, Zamboni G. Brain imaging in dementia. BMJ. 92(1088). http://pmj.bmj.com/content/92/1088/333. Accessed 29 Aug 2017.CrossRefGoogle Scholar
  60. 60.
    Yokota O. Frontotemporal lobar degeneration and dementia with Lewy bodies: clinic-pathological issues associated with antemortem diagnosis. Psychogeriatrics. 2009;9(2):91–102.CrossRefGoogle Scholar
  61. 61.
    Barber R, Panikkar A, McKeith IG. Dementia with Lewy bodies: diagnosis and management. Int J Geriatr Psychiatry. 2001;16(Suppl 1):S12–8.CrossRefGoogle Scholar
  62. 62.
    Gibbs WRG. Dementia and Parkinson’s disease. J Psychiatry. 1989;154:596–614.CrossRefGoogle Scholar
  63. 63.
    Jellinger KA. Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci. 2013;5:17.  https://doi.org/10.3389/fnagi.2013.00717.eCol.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Black SE. Therapeutic issues in vascular dementia: studies designs and approaches. Can J Neurol Sci. 2007;34(Suppl 1):S125–30.CrossRefGoogle Scholar
  65. 65.
    Eisenmenger LB, Huo EJ, Hoffmaan JM, Minoshima S, Matesan MC, Lewis DH, et al. Advances in PET imaging of degenerative cerebrovascular and traumatic causes of dementia. Semin Nucl Med. 2016;46(1):57–87.CrossRefGoogle Scholar
  66. 66.
    Kawas CH, Corrado M. Clinical, imaging and pathological studies in the oldest old: the 90+study. http://grantome.com/grant/NIH/R01-AG021055-12. Accessed 3 Apr 2016.
  67. 67.
    O’Brien JT. Role of imaging techniques in the diagnosis of dementia. Br J Radiol. 2007;80(2):S71–7.  https://doi.org/10.1259/bjr/33117326.CrossRefPubMedGoogle Scholar
  68. 68.
    Kawas CH, Kim RL, Sonneen JA, Bullain SS, Trieu T, Corrado MM. Multiple pathologies are common and related to dementia in the oldest old. The 90+ study. Neurology. 2015;85(6):535–42.CrossRefGoogle Scholar
  69. 69.
    Liu S, Cai W, Pijol S, Kikinis R, Feng DD. Alzheimer’s disease staging. Front Aging Neurosci. 2016;8:23.  https://doi.org/10.3389/fnagi.2016.00023.CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Pauwels EK, Volterrani D, Mariani G. Biomarkers for Alzheimer’s disease. Drugs News Perspect. 2009;22(3):151060.CrossRefGoogle Scholar
  71. 71.
    Del Sole A, Malaspina S, Magenta Biasina A. Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias. Funct Neurol. 2016;31(4):205215.Google Scholar
  72. 72.
    Narayanan L, Murray AD. What can imaging tell us about cognitive impairment and dementia? World J Radiol. 2016;8(3):240–54.CrossRefGoogle Scholar
  73. 73.
    Herholz K, Carter SF, Jones M. Positron emission tomography imaging in dementia. Br J Radiol. 2007;80(2):S160–7.  https://doi.org/10.1259/bjr/97295129.CrossRefPubMedGoogle Scholar
  74. 74.
    Atri A. Imaging of neurodegenerative cognitive and behavioural disorders: practical considerations for dementia clinical practice. Handb Clin Neurol. 2016;136:971–84.CrossRefGoogle Scholar
  75. 75.
    Tripathi M, Tripathi M, Damie N, Kushwaha S, Jaimini A, D’Souza MM, et al. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT. Neuroradiol J. 2014;27(1):13–21.CrossRefGoogle Scholar
  76. 76.
    Spehl TS, Hellwig S, Amtage F, Weiller C, Borman T, Weber WA, et al. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison t dementia with Lewy bodies and Alzheimer’s disease—a[F-18]-FDG pet study. J Neuroimaging. 2015;25(2):281–8.CrossRefGoogle Scholar
  77. 77.
    Kawas CH, Greenia DE, Bullain SS, Clark CM, Pontecorvo MJ, Joshi AD, et al. Amyloid imaging and cognitive decline in non-demented oldest –old: the 90+ study. Alzheimers Dement. 2013;9(2):199–203.CrossRefGoogle Scholar
  78. 78.
    Greenia D, Kawas C, Caunca M, Bullain S, Corrada M. PET Amyloid imaging with florbetapir predicts cognitive decline in the oldest old. Neurology. 2014;82(10 suppl P4 011).Google Scholar
  79. 79.
    Murray AD. Imaging approaches for dementia. Am J Neuroradiol (AJNR). 2012.  https://doi.org/10.3174/ajnr.A2782.CrossRefGoogle Scholar
  80. 80.
    Roman G, Pascual B. Contribution of neuroimaging to the diagnosis of Alzheimer’s disease and vascular dementia. Arch Med Res. 2012;43(8):671–6.CrossRefGoogle Scholar
  81. 81.
    Tatsch K. Imaging of dopaminergic system in differential diagnosis of dementia. Eur J Nucl Med Mol Imaging. 2008;35(Suppl 1):551–7.Google Scholar
  82. 82.
    McCleery J, Morgan S, Bradley KM, Noel-Storr AH, Ansorge O, Hyde C. Dopamine transporter imaging for the diagnosis of dementia wit Lewy bodies.  https://doi.org/10.1002/14651858.CD01633.pub2.
  83. 83.
    Stebbins GT, Murphy CM. Diffusion tensor imaging in Alzheimer’s disease and mild cognitive impairment. Behav Neurol. 2009;21(1):39–49.CrossRefGoogle Scholar
  84. 84.
    Chua TC, Wen W, Slavin MJ, Sachdev PS. Diffusion tensor imaging in mild cognitive impairment ad Alzheimer’s disease: a review. Curr Opin Neurol. 2008;21(1):83–92.CrossRefGoogle Scholar
  85. 85.
    Ukmar M, Makuc E, Onor ML, Garbin G, Trevisiol M, Cova MA. Evaluation of white matter damage in patients with Alzheimer’s diseases in patients with mild cognitive impairment using diffusion tensor imaging. Radiol Med. 2008;113(6):915–22.CrossRefGoogle Scholar
  86. 86.
    Naggara O, Oppenheim C, Rieu D, Raoux N, Rodrigo S, Dalla Barba G, et al. Diffusion tensor imaging in early Alzheimer’s disease. Psychiatry Res. 2006;146(3):243–9.CrossRefGoogle Scholar
  87. 87.
    Rosenberg RJ, Sziklas JJ, Spencer RP. Nuclear medicine studies of aging-1. Procedure utilization in the oldest old. Int J Rad Appl Instrum B. 1988;15(3):251–3.CrossRefGoogle Scholar
  88. 88.
    Fawcett R, McCoubne P. Pitfalls in imaging the frail elderly. Br J Radiology.  https://doi.org/10.1259/bjr20140699.
  89. 89.
    Melzer D, Tavakoly B, Winder RE, Mason JAH, Henley WE, Ble A, et al. Much more medicine for the oldest old: trends in UK electronic clinical records. Age Ageing. 2015;44:46–5.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Senan Nagaratnam
    • 1
  1. 1.Alfred Medical ImagingSydneyAustralia

Personalised recommendations